Address : 801 W Baltimore St, Baltimore, Maryland 21201-1109, United States
Phone Number : +1 732-537-6200
Industries : Research
Website : biologics.com
With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs.
Employees Total : 64
Revenue (Yearly) : 101M
Total Funding : 22.4M
Latest Funding : 5M
Hosting : Amazon AWS
Tech : Remote
Last Updated : 2023-12-20
Jubilant Biosys Limited research 5M yearly revenue |
Inno Bio Ventures Sdn Bhd biotechnology 10M yearly revenue |
Comparative Biosciences research 10M yearly revenue |
Mycenax Biotech Inc. biotechnology 140 employees |
CiVentiChem pharmaceuticals 1.6M yearly revenue |
Bismillah Engineers & Developers Ltd. Dhaka, Dhaka Division, Bangladesh Architecture & Planning |
Certica Solutions Wakefield, Massachusetts, United States E-learning |
Global Strategy Group New York, United States Public Relations & Communications |
Artworks Advertising Harare, Harare Province, Zimbabwe Marketing & Advertising |
Vedanta Biosciences, Inc. Cambridge, Massachusetts, United States Research |
Assembly Biosciences, Inc. South San Francisco, California, United States Research |